Synonyms- |
Introduction- |
Target |
Mechanism CD30 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date17 Sep 2019 |
Sponsor / Collaborator |
Start Date15 Jul 2016 |
Sponsor / Collaborator |